Intratumoral Hepatic Stellate Cells as a Poor Prognostic Marker and a New Treatment Target for Hepatocellular Carcinoma
Bin Sun(Tongji University), Zhengfeng Yin(Eastern Hepatobiliary Surgery Hospital), Lei Chen(Shanghai Third People's Hospital), Xianshuo Cheng(Kunming Medical University), Yu Zhang(Second Military Medical University), Lehua Shi(Second Military Medical University), Zhenyu Liu(Shanxi Agricultural University), Xiaofeng Zhang(Second Military Medical University), Mengchao Wu(Second Military Medical University), Haihua Qian(Nanjing University of Chinese Medicine)
Cited by 28
Related Papers
The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges
|Theranostics|2019|1k
Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
|Clinical Cancer Research|2017|562
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma
|JAMA Surgery|2018|546
Central focused convolutional neural networks: Developing a data-driven model for lung nodule segmentation
|Medical Image Analysis|2017|489
Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
|European Respiratory Journal|2019|441